N@N

Ironwood Pharmaceuticals Announces Upcoming Presentation at J.P. Morgan Healthcare Conference

^{Published on 2011-01-06 14:05:49 - Market Wire}
 

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--[ Ironwood Pharmaceuticals, Inc. ] (NASDAQ: IRWD) will present at the 29^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2011 at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time at The Westin St. Francis in San Francisco. The presentation will be followed by a question and answer session that will begin at approximately 11:30 a.m. Pacific Time / 2:30 p.m. Eastern Time.

A live webcast of both the presentation and the question and answer session will be accessible through the Investors section of Ironwooda™s website at [ www.ironwoodpharma.com ]. To access the webcasts, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of each webcast will be available on Ironwooda™s website for 14 days following the conference.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwooda™s GCaC agonist, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation (IBSaC) and chronic constipation. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is located in Cambridge, Mass. To learn more, visit [ www.ironwoodpharma.com ].